États-Unis · Plateformes & données · The Motley Fool

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Publié par The Motley Fool · États-Unis il y a 2 h

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

À lire aussi

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shares to Pay Dividend of $0.03

Couche-Tard makes bid for Cumberland Farms: report

Albanian police fire tear gas as anti-government student protests turn violent

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Partager

À lire aussi

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shares to Pay Dividend of $0.03

Couche-Tard makes bid for Cumberland Farms: report

Albanian police fire tear gas as anti-government student protests turn violent

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem